MC2071A1 - Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant - Google Patents

Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant

Info

Publication number
MC2071A1
MC2071A1 MC892078A MC2078A MC2071A1 MC 2071 A1 MC2071 A1 MC 2071A1 MC 892078 A MC892078 A MC 892078A MC 2078 A MC2078 A MC 2078A MC 2071 A1 MC2071 A1 MC 2071A1
Authority
MC
Monaco
Prior art keywords
processes
preparation
pharmaceutical formulations
formulations containing
nucleoside derivatives
Prior art date
Application number
MC892078A
Other languages
English (en)
French (fr)
Inventor
Rahim Saad
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC2071A1 publication Critical patent/MC2071A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MC892078A 1988-11-23 1989-11-22 Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant MC2071A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827339A GB8827339D0 (en) 1988-11-23 1988-11-23 Antiviral compounds

Publications (1)

Publication Number Publication Date
MC2071A1 true MC2071A1 (fr) 1990-10-03

Family

ID=10647307

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892078A MC2071A1 (fr) 1988-11-23 1989-11-22 Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant

Country Status (25)

Country Link
EP (1) EP0375164B1 (de)
JP (1) JPH0753748B2 (de)
CN (1) CN1022570C (de)
AT (1) ATE104676T1 (de)
AU (1) AU620471B2 (de)
CA (1) CA2003607A1 (de)
DD (1) DD289534A5 (de)
DE (1) DE68914809T2 (de)
DK (1) DK586489A (de)
ES (1) ES2063147T3 (de)
FI (1) FI895572A0 (de)
GB (1) GB8827339D0 (de)
HU (1) HU204842B (de)
IE (1) IE893731L (de)
IL (1) IL92402A0 (de)
MC (1) MC2071A1 (de)
MY (1) MY104976A (de)
NO (1) NO171168C (de)
NZ (1) NZ231478A (de)
PH (1) PH26745A (de)
PL (1) PL162956B1 (de)
PT (1) PT92375B (de)
RU (1) RU1831486C (de)
YU (1) YU47096B (de)
ZA (1) ZA898926B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69116750T2 (de) * 1990-07-04 1996-11-14 Merrell Dow Pharma 9-Purinyl-Phosphonsäurederivate
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
GB9125271D0 (en) * 1991-11-27 1992-01-29 Wellcome Found Anti-hbv pyrimidine nucleoside
WO2022008025A1 (en) * 2020-07-05 2022-01-13 Since & Technology Development Fund Authority 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
GB8629892D0 (en) * 1986-12-15 1987-01-28 Wellcome Found Antiviral compounds
EP0346108A3 (de) * 1988-06-09 1991-04-24 The Wellcome Foundation Limited Anti-infektiöse Nukleoside

Also Published As

Publication number Publication date
PT92375B (pt) 1995-07-18
YU221289A (en) 1991-02-28
ATE104676T1 (de) 1994-05-15
DE68914809D1 (de) 1994-05-26
DK586489D0 (da) 1989-11-22
DK586489A (da) 1990-05-24
NO171168C (no) 1993-02-03
NO894658D0 (no) 1989-11-22
RU1831486C (ru) 1993-07-30
NO894658L (no) 1990-05-25
YU47096B (sh) 1994-12-28
DD289534A5 (de) 1991-05-02
ZA898926B (en) 1991-07-31
HU204842B (en) 1992-02-28
EP0375164A1 (de) 1990-06-27
PT92375A (pt) 1990-05-31
CA2003607A1 (en) 1990-05-23
IL92402A0 (en) 1990-07-26
DE68914809T2 (de) 1994-08-11
HUT52110A (en) 1990-06-28
MY104976A (en) 1994-07-30
AU620471B2 (en) 1992-02-20
JPH0327394A (ja) 1991-02-05
JPH0753748B2 (ja) 1995-06-07
PH26745A (en) 1992-09-28
ES2063147T3 (es) 1995-01-01
PL162956B1 (pl) 1994-01-31
FI895572A0 (fi) 1989-11-22
GB8827339D0 (en) 1988-12-29
EP0375164B1 (de) 1994-04-20
CN1022570C (zh) 1993-10-27
HU896136D0 (en) 1990-02-28
NO171168B (no) 1992-10-26
IE893731L (en) 1990-05-23
AU4544289A (en) 1990-06-14
CN1042916A (zh) 1990-06-13
NZ231478A (en) 1992-09-25

Similar Documents

Publication Publication Date Title
DK224286A (da) 2',3'-dideoxy-nucleosider
MC1935A1 (fr) Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant
AU4690989A (en) Antiviral cytosine and guanine derivatives
DE3679353D1 (de) Antivirale verbindungen.
ATE71840T1 (de) Virushemmende nukleosidmischung.
MC2071A1 (fr) Procedes pour la preparation de derives de nucleosides antiviraux et de formulations pharmaceutiques les contenant
DK291390A (da) Terapeutiske anvendelser af 2',5'-oligoadenylatderivater

Legal Events

Date Code Title Description
YP Annual fee paid